Science Explorer Back to mapMap
Discussion
Researcher · Simcere Pharmaceutical (China) · China

Feng C. Zhou

Feng C. Zhou publishes mostly in Molecular Biology, Oncology and Immunology, on topics such as Myeloproliferative Neoplasms: Diagnosis and Treatment, Multiple Myeloma Research and Treatments and Prenatal Substance Exposure Effects.

ORCID 0009-0007-3050-6239 OpenAlex
World rank
#2,877,430
of 7,710,434 ranked researchers
Rank in China
#452,179
of 978,568
Works
134
Citations
2.4k
Citations per work
17.7
h-index
29
i10-index 47Top 16% in Molecular Biology
Feng C. Zhou

What does Feng C. Zhou research?

Feng C. Zhou's work is mostly in Biochemistry, Genetics and Molecular Biology (29%), Medicine (20%), Immunology and Microbiology (6%).

Everything else: 61 works · 45.4% of their workLife Sciences: 46 works · 34.3% of their workBiochemistry, Genetics and Molecular Biology: 38 works · 28.7% of their workMolecular Biology: 32 works · 23.7% of their workCancer Research: 7 works · 5.0% of their workImmunology and Microbiology: 8 works · 5.6% of their workImmunology: 8 works · 5.6% of their workHealth Sciences: 27 works · 20.3% of their workMedicine: 27 works · 20.3% of their workOncology: 13 works · 10.0% of their workPediatrics, Perinatology and Child Health: 7 works · 5.3% of their workPulmonary and Respiratory Medicine: 7 works · 5.0% of their workTHEIR WORKFeng C. Zhou134works
Life Sciences34%Health Sciences20%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else6145.4%
    1. Biochemistry, Genetics and Molecular Biology3828.7%
    2. Immunology and Microbiology85.6%
    1. Medicine2720.3%
  1. 1Molecular Biology24% of their works
  2. 2Oncology10% of their works
  3. 3Immunology6% of their works
  4. 4Pediatrics, Perinatology and Child Health5% of their works
  5. 5Pulmonary and Respiratory Medicine5% of their works
  6. 6Cancer Research5% of their works

Research topics

Which keywords describe Feng C. Zhou's research?

The keywords of their largest research topics: Diagnosis Criteria, International Myeloma Working Group, JAK2 Mutation, Myelofibrosis, Fetal Alcohol Syndrome, Prenatal Alcohol Exposure, BET Bromodomains and CAR T Cells.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 16 words, with their numbers
  1. Diagnosis Criteria101 topic
  2. International Myeloma Working Group101 topic
  3. JAK2 Mutation101 topic
  4. Myelofibrosis101 topic
  5. Fetal Alcohol Syndrome71 topic
  6. Prenatal Alcohol Exposure71 topic
  7. BET Bromodomains61 topic
  8. CAR T Cells61 topic
  9. Chimeric Antigen Receptor61 topic
  10. Hepatic Stellate Cells61 topic
  11. Liver Regeneration61 topic
  12. NK Cell Recognition61 topic
  13. Natural Killer Cells61 topic
  14. PROTACs61 topic
  15. Wnt Signaling51 topic
  16. ß-Catenin51 topic

Where does Feng C. Zhou work?

Feng C. Zhou's main affiliation in the publication record is Simcere Pharmaceutical (China), China.

How many publications and citations does Feng C. Zhou have?

OpenAlex counts 134 works and 2,367 citations for Feng C. Zhou, an h-index of 29, ranking #2,877,430 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Other researchers named Feng C. Zhou

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Feng C. Zhou. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.